A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003)

Conditions: Malaria Interventions: Other: Plasmodium falciparum; Drug: MK-7602; Drug: Artemether/lumefantrine; Drug: Primaquine; Drug: Artesunate; Drug: Atovaquone/proguanil Sponsors: Merck Sharp& Dohme LLC Not yet recruiting

https://clinicaltrials.gov/study/NCT06294912

Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials

More News: Malaria | Merck | Research | Study